PAPER Gaynor LS, Curiel Cid RE, Penate A, Rosselli M, Burke SN, Wicklund M, Loewenstein DA, Bauer RM
SEARCH RESULTS
3923 RESULTS
PAPER Koole M, Lohith TG, Valentine JL, Bennacef I, Declercq R, Reynders T, Riffel K, Celen S, Serdons K, Bormans G, Ferry-Martin S, Laroque P, Walji A, Hostetler ED, Briscoe RJ, de Hoon J, Sur C, Van Laere K, Struyk A
Preclinical Safety Evaluation and Human Dosimetry of [18F]MK-6240, a Novel PET Tracer for Imaging Neurofibrillary Tangles.
Mol Imaging Biol. 2019 May 20; PubMed: 31111397PAPER Verkhratsky A
Astroglial Calcium Signaling in Aging and Alzheimer's Disease.
Cold Spring Harb Perspect Biol. 2019 Jul 1;11(7) PubMed: 31110130PAPER Hartlage-Rübsamen M, Ratz V, Zeitschel U, Finzel L, Machner L, Köppen J, Schulze A, Demuth HU, von Hörsten S, Höfling C, Roßner S
Endogenous mouse huntingtin is highly abundant in cranial nerve nuclei, co-aggregates to Abeta plaques and is induced in reactive astrocytes in a transgenic mouse model of Alzheimer's disease.
Acta Neuropathol Commun. 2019 May 20;7(1):79. PubMed: 31109380PAPER Krejciova Z, Carlson GA, Giles K, Prusiner SB
Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein.
Acta Neuropathol Commun. 2019 May 20;7(1):81. PubMed: 31109379PAPER Petit D, Hitzenberger M, Lismont S, Zoltowska KM, Ryan NS, Mercken M, Bischoff F, Zacharias M, Chávez-Gutiérrez L
Extracellular interface between APP and Nicastrin regulates Aβ length and response to γ-secretase modulators.
EMBO J. 2019 Jun 17;38(12) Epub 2019 May 20 PubMed: 31109937PAPER Kuo YC, Rajesh R
Challenges in the treatment of Alzheimer's disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors.
Expert Rev Neurother. 2019 Jul;19(7):623-652. Epub 2019 May 29 PubMed: 31109210PAPER Uehara T, Choong CJ, Nakamori M, Hayakawa H, Nishiyama K, Kasahara Y, Baba K, Nagata T, Yokota T, Tsuda H, Obika S, Mochizuki H
Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease.
Sci Rep. 2019 May 21;9(1):7567. PubMed: 31110191PAPER Sun J, Wang L, Bao H, Premi S, Das U, Chapman ER, Roy S
Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling.
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11113-11115. Epub 2019 May 20 PubMed: 31110017PAPER Atias M, Tevet Y, Sun J, Stavsky A, Tal S, Kahn J, Roy S, Gitler D
Synapsins regulate α-synuclein functions.
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11116-11118. Epub 2019 May 20 PubMed: 31110014PAPER Dhillon JS, Trejo-Lopez JA, Riffe C, Levites Y, Sacino AN, Borchelt DR, Yachnis AY, Giasson BI
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
Acta Neuropathol Commun. 2019 May 20;7(1):80. PubMed: 31109378PAPER Wang X, Chang C, Wang D, Hong S
Systematic profiling of SH3-mediated Tau-Partner interaction network in Alzheimer's disease by integrating in silico analysis and in vitro assay.
J Mol Graph Model. 2019 Jul;90:265-272. Epub 2019 May 8 PubMed: 31112821PAPER Panza F, Lozupone M, Watling M, Imbimbo BP
Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?
Expert Rev Neurother. 2019 Jul;19(7):599-602. Epub 2019 May 27 PubMed: 31112433PAPER Liu K, Liu Y, Xu Y, Nandakumar KS, Shen X, Lin J, Li C, He C, Zhou C
Regulatory role of Golgi brefeldin A resistance factor-1 in amyloid precursor protein trafficking, cleavage and Aβ formation.
J Cell Biochem. 2019 Sep;120(9):15604-15615. Epub 2019 May 20 PubMed: 31111546PAPER Li X, Smid SD, Lin J, Gong Z, Chen S, You F, Zhang Y, Hao Z, Lin H, Yu X, Jin X
Neuroprotective and Anti-Amyloid β Effect and Main Chemical Profiles of White Tea: Comparison Against Green, Oolong and Black Tea.
Molecules. 2019 May 19;24(10) PubMed: 31109117Current Filters
- Date Range : May 2019 to Aug 2019 x